Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.89 USD | -2.99% | -4.71% | 0.00% |
May. 14 | Goldman Sachs Upgrades CG Oncology to Buy From Neutral With $50 Price Target | MT |
May. 09 | CG Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Neutral | Neutral |
Resistance | 33.54 | 47.93 | 47.93 |
Spread/Res. | -12.02% | -38.43% | -38.43% |
Spread/Supp. | +14.20% | +14.20% | +3.54% |
Support | 25.84 | 25.84 | 28.50 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- CGON Stock
- Charts CG Oncology, Inc.